0001434316-11-000002.txt : 20110420
0001434316-11-000002.hdr.sgml : 20110420
20110419180148
ACCESSION NUMBER: 0001434316-11-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20110420
DATE AS OF CHANGE: 20110419
EFFECTIVENESS DATE: 20110420
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-158650
FILM NUMBER: 11768997
BUSINESS ADDRESS:
STREET 1: 3535 GENERAL ATOMICS COURT
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 3535 GENERAL ATOMICS COURT
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
D
1
primary_doc.xml
X0704
D
LIVE
0001434316
FATE THERAPEUTICS INC
3535 GENERAL ATOMICS COURT
SUITE 200
SAN DIEGO
CA
CALIFORNIA
92121
858.875.1803
DELAWARE
None
None
Corporation
true
2007
Scott
Wolchko
c/o Fate Therapeutics Inc.
3535 General Atomics Court, Suite 200
San Diego
CA
CALIFORNIA
92121
Executive Officer
John
Mendlein
c/o Fate Therapeutics Inc.
3535 General Atomics Court, Suite 200
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Amir
Nashat
c/o Polaris Venture Partners
1000 Winter Street, Suite 3350
Waltham
MA
MASSACHUSETTS
02451
Director
Carl
Weissman
c/o OVP Venture Partners
1010 Market Street
Kirkland
WA
WASHINGTON
98033
Director
Bryan
E.
Roberts
c/o Venrock Associates
3340 Hillview Avenue
Palo Alto
CA
CALIFORNIA
94304
Director
Robert
T.
Nelsen
c/o ARCH Venture Partners
8725 West Higgins Road, Suite 290
Chicago
IL
ILLINOIS
60631
Director
Daniel
Shoemaker
c/o Fate Therapeutics Inc.
3535 General Atomics Court, Suite 200
La Jolla
CA
CALIFORNIA
92121
Executive Officer
Biotechnology
Decline to Disclose
- 06
false
2011-03-30
false
true
false
0
1000000
1000000
0
false
1
0
0
0
false
FATE THERAPEUTICS INC
/s/ Scott Wolchko
Scott Wolchko
Chief Financial Officer
2011-04-18